Showing results (1-10 of 464) with videos related to
Sort By:
Pageof 47
Clinical Therapeutics|January 1, 1985
Nebulized amoxicillin in chronic purulent bronchiectasisR A Stockley, S L Hill, D BurnettThe Journal of Antimicrobial Chemotherapy|November 1, 1989
Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanateR A Stockley, P Dragicevic, D Burnett, et al.Lancet (London, England)|November 7, 1987
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysisD Burnett, A Chamba, S L Hill, et al.Clinical Science (London, England : 1979)|June 1, 1988
Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretionsR A Stockley, J Shaw, S L Hill, et al.Clinical Science (London, England : 1979)|July 1, 1989
Effects of plasma, tumour necrosis factor, endotoxin and dexamethasone on extracellular proteolysis by neutrophils from healthy subjects and patients with emphysemaD Burnett, A Chamba, S L Hill, et al.The Quarterly Journal of Medicine|February 1, 1988
The response of patients with purulent bronchiectasis to antibiotics for four monthsS L Hill, D Burnett, K A Hewetson, et al.Antimicrobial Agents and Chemotherapy|July 1, 1992
Use of an enzyme-linked immunosorbent assay to assess penetration of amoxicillin into lung secretionsS L Hill, D Burnett, A L Lovering, et al.Respiratory Medicine|March 1, 1990
IgA subclasses in sputum from patients with bronchiectasisD Burnett, S L Hill, A R Bradwell, et al.Thorax|July 1, 1986
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalationS L Hill, H M Morrison, D Burnett, et al.Thorax|August 26, 1998
IgG subclasses in the serum and sputum from patients with bronchiectasisS L Hill, J L Mitchell, D Burnett, et al.Pageof 47